Weight loss drugs that are not injections: what your options actually are

Step 1: Understand which non-injection options are actually licensed

The question of weight loss drugs that are not injections has a clearer answer now than it did even a year ago, and our non-injection weight loss drugs page covers the full picture of what is currently licensed. Two distinct types of oral medicine hold UK licences for weight management in adults.

The first is orlistat, a capsule taken three times daily with meals. It works by inhibiting the gut enzyme lipase, which the body uses to break down dietary fat, roughly a third of the fat you eat passes through unabsorbed rather than being stored. Orlistat has been available in the UK for many years in both prescription and pharmacy (lower-strength) forms. The NHS orlistat page sets out who it is suitable for and what to expect.

The second, and newer, is Wegovy tablets, oral semaglutide co-formulated with an absorption enhancer called SNAC. On 11 June 2026 the MHRA approved it as the first oral GLP-1 medicine licensed in the UK for weight management. This is the same active ingredient as the Wegovy injection, but taken as a once-daily tablet rather than a weekly pen. It is licensed for adults with a BMI of 30 or above, or 27–29.9 with at least one weight-related condition such as high blood pressure or type 2 diabetes. You can read more about how all the currently licensed weight-loss injection drugs compare if you are weighing up both routes.

It is worth being precise about what is not on this list. Rybelsus is also oral semaglutide, but it is licensed for type 2 diabetes at different doses, not for weight management. The same applies to Ozempic. Neither should be obtained or used for weight loss.

Step 2: Know what the evidence says about oral GLP-1 treatment

The clinical data for Wegovy tablets comes primarily from the OASIS 4 phase-3 trial: 307 adults with obesity or overweight and at least one weight-related condition, without diabetes, followed over 64 weeks alongside lifestyle changes. Participants taking the 25mg maintenance dose lost an average of around 13.6% of their body weight, compared with roughly 2.4% on placebo. Among those who adhered fully to treatment throughout, average weight loss was approximately 16.6%.

Those figures are meaningful but sit below the results seen in the injectable GLP-1 trials. The STEP 1 trial for the Wegovy 2.4mg injection reported around 15% average weight loss over 68 weeks, and tirzepatide (Mounjaro, a dual GIP/GLP-1 receptor agonist) reached around 20–21% in the SURMOUNT-1 trial at the highest dose. For a thorough breakdown of how the weight-loss injection results compare, that page covers the evidence in detail.

The most common side effects in the OASIS 4 trial were gastrointestinal (nausea, diarrhoea, constipation and vomiting) reported in about 74% of participants on oral semaglutide compared with 42% on placebo. Most were mild to moderate and settled as the body adjusted. The MHRA's Yellow Card scheme lets anyone report suspected side effects from any medicine, which remains open throughout your treatment.

One practical advantage of tablets over pens: no refrigeration. The Wegovy tablet is stored at room temperature, which makes it straightforward to carry when travelling or to slot into a morning routine, before the kettle goes on, on an empty stomach, with a small sip of plain water, waiting at least 30 minutes before eating or drinking anything else.

Step 3: Check whether you actually need an injection at all, or vice versa

Some people search for non-injection options because needles are genuinely off-putting. That is an entirely reasonable starting point, and the oral GLP-1 route now gives prescribers a real alternative to discuss. Others arrive at the question from the opposite direction: they have been told tablets exist, but they want to understand whether the injection might produce better results for their situation, and our page covering weight loss drugs and injections sets out how the injectable options work and what to expect from them.

The honest answer is that which medicine is appropriate for you depends on your full clinical picture: your BMI, any existing conditions, your medication history, how you have responded to previous weight-management attempts, and what your prescriber concludes after reviewing all of that. A BMI figure alone does not settle it. For context on how weight-loss treatment options sit alongside each other, that page outlines what is available through a structured clinical consultation.

There is also a cost dimension worth understanding plainly. Non-injection does not mean lower cost, the Wegovy tablet is a newly approved prescription medicine and private pricing reflects that. Our weight-loss overview page explains what a private prescription for any of these medicines typically involves, without hiding what is included. For a direct comparison of the injectable and non-injectable routes, the question of whether all weight-loss drugs are injections addresses that specifically.

Step 4: Access it through a route you can verify

All of the medicines on this page are prescription-only. The legal route is a consultation with a qualified prescriber, a clinical assessment, and a prescription issued through a GPhC-registered pharmacy. There is no shortcut that is also safe.

Online pharmacies are a legitimate route, but only if they appear on the GPhC register, which you can check at pharmacyregulation.org/registers. Sellers offering prescription weight-loss medicines without a prior consultation, via social media, or at prices that seem too low to be real, are almost certainly not operating legally. The MHRA has warned publicly about fake weight-loss products circulating online; the risks include medicines that contain the wrong active ingredient or none at all.

At nume, every consultation is read and assessed by a GPhC-registered Independent Prescriber, a real clinician, not software. Our pharmacy holds GPhC premises registration 9012878, verifiable directly on the register. If you are based in Northern Ireland and want to understand what is available locally, our weight loss injections Newry page explains the options we can support you with from there. If you are curious about the clinical team behind the service, our lead prescriber's profile is on the site. And if a question about your current situation is not answered here, the FAQs page or our contact team can help. When you are ready, checking your eligibility starts a free consultation with no obligation.